Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Arwa A. Alzaghal"'
Autor:
Arwa A. Alzaghal, Guru Sonpavde, Francesco Alessandrino, Atul B. Shinagare, Amin Nassar, Arvind Ravi, Rahul Gujrathi, Bradley Alexander McGregor
Publikováno v:
European Urology Oncology. 3:680-686
Reliable biomarkers to predict the response of metastatic urothelial cancer (mUC) to programmed death-1 and programmed death-ligand 1 (PD-1/PD-L1) inhibitors are being investigated. Texture analysis represents tumor heterogeneity and may serve as a p
Publikováno v:
Clinical Imaging. 50:43-50
In this pictorial essay, the authors discuss etiologies, imaging findings with focus on fluoroscopy and management of the short esophagus in children and adults.
Autor:
Arwa A. Alzaghal, Pamela J. DiPiro
Publikováno v:
Current Oncology Reports. 20
Advanced mammographic imaging modalities have been implemented in clinical practices throughout the USA. The most notable and widely used has been the three-dimensional derivative of digital mammography, known as digital breast tomosynthesis (DBT). I
Autor:
Guru Sonpavde, Francesco Alessandrino, Bradley Alexander McGregor, Arwa A. Alzaghal, Atul B. Shinagare, Rahul Gujrathi, Amin Nassar, Arvind Ravi
Publikováno v:
Journal of Clinical Oncology. 37:424-424
424 Background: Reliable biomarkers to predict response of urothelial cancer to PD-1/PD-L1 inhibitors are still being investigated. Texture analysis represents underlying tumor heterogeneity and may serve as a predictor of response in urothelial canc
Autor:
Alessandrino F; Department of Imaging, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Gujrathi R; Department of Imaging, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Nassar AH; Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Alzaghal A; Department of Imaging, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Ravi A; Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute, Cambridge, MA, USA., McGregor B; Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Sonpavde G; Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Shinagare AB; Department of Imaging, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: ashinagare@bwh.harvard.edu.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2020 Oct; Vol. 3 (5), pp. 680-686. Date of Electronic Publication: 2019 Mar 09.